Coya Therapeutics, Inc.

General ticker "COYA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $100.7M (TTM average)

Coya Therapeutics, Inc. follows the US Stock Market performance with the rate: 16.6%.

Estimated limits based on current volatility of 3.5%: low 5.37$, high 5.76$

Factors to consider:

  • Total employees count: 6 as of 2022
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [3.36$, 7.57$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.92$, 6.64$]

Financial Metrics affecting the COYA estimates:

  • Positive: with PPE of -5.6 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -12.33 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Positive: Shareholder equity ratio, % of 89.24 > 63.39
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of -0.03 > -0.66
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term COYA quotes

Long-term COYA plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $6.00MM $3.55MM
Operating Expenses $9.81MM $13.91MM $20.80MM
Operating Income $-9.81MM $-7.90MM $-17.25MM
Non-Operating Income $-2.43MM $0.64MM $1.65MM
R&D Expense $4.94MM $6.04MM $11.89MM
Income(Loss) $-12.24MM $-7.26MM $-15.60MM
Taxes $0.00MM $0.72MM $-0.72MM
Profit(Loss)* $-12.24MM $-7.99MM $-14.88MM
Stockholders Equity $-8.39MM $35.64MM $39.58MM
Assets $8.40MM $41.26MM $44.35MM
Operating Cash Flow $-7.24MM $-11.19MM $-10.29MM
Investing Cash Flow $-0.53MM $-0.54MM $-0.03MM
Financing Cash Flow $9.36MM $38.43MM $16.03MM
Earnings Per Share** $-1.23 $-0.79 $-0.98

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.